Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.39 |
| ▸ | TTR | P02766 | 1/20 | 0.39 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21728175 | 0.85 | ACHE (0.59) | MRGPRX4ALDH1A1MAPTACHELMNA | |
| SCHEMBL31285761 | 0.83 | MRGPRX4 (0.46) | MRGPRX4ALDH1A1MAPTACHELMNA | |
| SCHEMBL8463126 | 0.82 | POLB (0.56) | ALDH1A1MAPTACHELMNAPOLB | |
| SCHEMBL24309423 | 0.81 | HPGD (0.50) | MRGPRX4ALDH1A1MAPTACHELMNA | |
| SCHEMBL19979061 | 0.80 | MRGPRX4 (0.43) | MRGPRX4ALDH1A1MAPTACHELMNA | |
| SCHEMBL27952004 | 0.80 | MRGPRX4 (0.47) | MRGPRX4ALDH1A1MAPTACHELMNA | |
| SCHEMBL3918667 | 0.80 | TSHR (0.45) | MRGPRX4ALDH1A1MEN1CYP1A2CYP3A4 | |
| SCHEMBL695666 | 0.79 | PTK2B (0.50) | ALDH1A1MAPTLMNAPOLBMEN1 | |
| SCHEMBL11285158 | 0.78 | MRGPRX4 (0.45) | MRGPRX4ALDH1A1LMNAPOLBMEN1 | |
| SCHEMBL27698905 | 0.76 | MAPK1 (0.44) | MRGPRX4ALDH1A1MAPTLMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107406374-B | Process for preparing 3-chloro-2-vinylphenyl sulfonate | 拜耳作物科学股份公司 | 2020-07-14 | — | — | CN | disclosed |
| US-10618872-B2 | Process for preparing 3-chloro-2-vinylphenylsulfonates | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-04-14 | — | — | US | disclosed |
| EP-3265439-B1 | PROCESS FOR PREPARING 3-CHLORO-2-VINYLPHENYLSULFONATES | BAYER CROPSCIENCE AG (DE) | 2019-03-27 | — | — | EP | disclosed |
| US-20180079717-A1 | PROCESS FOR PREPARING 3-CHLORO-2-VINYLPHENYLSULFONATES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-03-22 | — | — | US | disclosed |
| US-20180079717-A1 | PROCESS FOR PREPARING 3-CHLORO-2-VINYLPHENYLSULFONATES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180079717-A1 | PROCESS FOR PREPARING 3-CHLORO-2-VINYLPHENYLSULFONATES | AGPS, VARS1, VPS4B | MRGPRX4 4108/4885ALDH1A1 3434/4885MAPT 4617/4885 |
| US-10618872-B2 | Process for preparing 3-chloro-2-vinylphenylsulfonates | AGPS, VARS1, VPS4B | MRGPRX4 4108/4885ALDH1A1 3434/4885MAPT 4617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.